Information about Cancer Research and Various Advancements

Cancer research is said to be the basic study into cancer for identifying the causes as well as development strategies for diagnosis, cure, prevention and treatment. The research may range from molecular bioscience, epidemiology to the act of certain clinical trials for evaluating as well as comparing the applications of several cancer treatments. The applications may include radiation therapy, hormone therapy, surgery, chemotherapy, immunotherapy and various other combined cure modalities like chemo-radiotherapy. There are many areas of research in this type. In general, it may include many disciplines which may comprise of diet, genetics, environmental factors etc.

 

With regards to the investigation of the potential targets and causes for therapy, the main track used up will start from the information which is received from the clinical observation. Mouse is most often used as the mammalian ideal for the manipulation of function of the genes which plays a vital role in the formation of tumor. However, the basic characteristics of the tumor initiation like mutagenesis are being assayed on the cultures of mammalian cells and bacteria. There are several important cells which are involved in the cancer growth. You can get more information regarding all these cells when you browse over the web.

 

Currently, there are several hospitals are providing treatment for curing cancer. It is always better to get the right treatment during the early stages itself. Some of the recent topics which are included in the cancer research treatment may include Photodynamic therapy, Targeted therapy, Anti-cancer vaccine, Reoviridae (often known as Reolysin drug therapy) etc. Some of the cancer research areas have provided amazing results within the past few years. This was being accomplished by helping out the cancer patients in reversing the aliment by properly eliminating the cells causing cancer.

 

This technique was found to achieve huge success and was found to be very effective as it helps the individuals from the development of the disease during the primary place itself. Breast cancer and prostate cancer is found to be listed among the treatable forms of cancer. The treatment plans are often carried out without making use of chemotherapy. Recent reports have proved that a compound which is commonly seen in the red wine known as Resveratrol have helped the patients who are suffering from prostate cancer as well as breast cancer. Resveratrol is considered as a natural compound which is obtained from fruits like grapes, nuts, berries and others.

 

On the other hand, the source from which you are obtaining this compound is a very vital factor as it may vary in strength. Among the various fruits, reports have shown that, grapes is the best source for obtaining Resveratrol and the correct liquid form of it is the Red Wine. It also helps in curing liver cancer as well as various liver problems to some extent. Cellular therapy is yet another method which is found to be far better than carrying out chemotherapy. However, consulting your physician and getting the right treatment plan at the right period of time will prevent the further growth of cancer cells in your body.

The Ovarian Cancer Research And Information Amendments Of 2001

Mr. Speaker, I rise today to announce that I am today introducing the Ovarian Cancer and Research Amendments of 2001. I am proud to be joined by 56 original co-sponsors and would like to invite the rest of my colleagues to join me in support of the bill.
Ovarian cancer is the most lethal cancer of the female reproductive system, primarily because it is so difficult to detect in its early stages. While survival rates are quite high if the disease is found before it spread beyond the ovaries, the five-year survival rate drops to 28% for women who are diagnosed and treated in the later stages of the disease. Only 25% of ovarian cancer cases are caught in the earliest stages.
The Ovarian Cancer and Research Amendments of 2001 have three components. First, it authorizes $150 million for ovarian cancer research: one- half to be spent on basic cancer research and one-half on clinical trials and treatment. The bill requires that priority be given to developing a test for the early detection of ovarian cancer; research to identify precursor lesions and to determine the manner in which benign conditions progress to malignant status; and research to determine the relationship between ovarian cancer and endometriosis. Moreover, the bill requires that appropriate counseling be provided to women participating in clinical trials.   Second, the bill provides for a comprehensive education program to provide information to patients and the public on screening procedures, the genetic basis to ovarian cancer, factors that increase the risk of getting ovarian cancer; and any new treatments for ovarian cancer.   Finally, it requires that the National Cancer Advisory Board include at least one individual who is at high risk of developing ovarian cancer.  I hope all my colleagues will join me in supporting this worthy cause and help to give women a fighting chance against ovarian cancer.

“Men ‘in denial’ over weight gain” (BBC/Cancer Research UK)

Around a quarter of British men are “in denial” about their waist measurement, a Cancer Research UK survey suggests. Official statistics show that 65% of adult men are overweight or obese, but the survey of over 2,000 men found only 40% thought they were in these groups. Most of the men questioned were unaware being overweight or obese, or inactive, increases the risk of cancer. Experts urged overweight men to become more active and eat a balanced diet rich in fruit and vegetables.

The survey was released to launch Cancer Research UK’s Man Alive Campaign. Around 65% of those questioned had no idea that being overweight or obese increased their chance of developing cancer, with 75% not aware that being physically inactive also increased their risk. The survey also found just 22% of those questioned eat five portions of fruit and vegetables per day, and two-thirds fail to meet the recommended target of 30 minutes of moderate exercise five times a week. Cancer Research UK experts said men were not heeding health warnings to maintain a healthy body weight.

Women ‘aware’

They warned obesity could be responsible for as many as 40,005 cases of cancer in UK men every year. Recently published research suggested obesity increases the risk of bowel cancer by 60%. Being obese also doubles the risk of being diagnosed with kidney, oesophageal and stomach cancer, as well as being a risk factor for bladder cancer. Good diet and regular exercise are two factors that can help in reducing the risk of developing cancer, they said. Professor Jane Wardle, the director of Cancer Research UK’s Health Behaviour Unit, said: “In the space of 10 years, the rate of obesity for British men has increased two thirds.

“Women are overweight too but our research shows that more of them know they have a problem and that’s the first step in putting it right.” She added: “Men need to be made aware of the problem, know how to fix the problem and be given the support to succeed. “Only then will they reduce their risk of cancer.” ‘Wake up call’ Dr Lesley Walker, director of information at Cancer Research UK, said: “It’s vital that men understand how they can reduce their risk of cancer.”The best present that anyone can give themselves is to stop smoking; it is by far the most important step in reducing cancer risk.” But she added: “In men who don’t smoke, obesity is one of the biggest known causes of preventable cancer.

“With rates of obesity for UK men growing faster than anywhere else in Europe, we are sounding a wake up call to all men and their partners to become more active, eat healthier diets and make sensible lifestyle choices. “To lose those spare tyres, be more active and eat a balanced diet that is rich in fruit and veg and low in sugar and fat.”

 

Viral Cancer Research – 1959

Surgeon Fired by Son’s Death Finds Virus May Cause Cancer

ATLANTIC CITY, Sept. 28 – When Dr. James T. Grace yr. watched his two-year old son die of leukemia in 1955, the medical part of his mind thought of one thing: infection. Healthy, playful one day, the child’s temperature shot up to 105 degrees the next; his glands swelled; he became toxic and in a few months he was dead.

So Dr. Grace gave up his private practice of surgery in Nashville, Tenn., and set out to discover if leukemia, the blood cancer that killed James T. Grace 3d, was caused by a germ — a virus perhaps. He moved to the Roswell Park Cancer Research Institute in Buffalo, N.Y.    Today Dr. Grace told the American College of Surgeons’ annual meeting here that he has evidence that not only leukemia but other human cancers as well may be caused by an infectious agent.

By grinding up malignant cancers cut from leukemia and other cancer victims, Dr. Grace and his Buffalo colleagues have infected mice with the human disease. They are first to do it on a large scale. Their evidence suggests but does not prove that a virus may be the culprit in the human ailment in the same way that the viruses caused the disease in animals. It is an infection; however, it is a strange kind of infection: you have to get it before or soon after birth.

So important do scientists consider the new finding that $500,000 has been obtained to narrow the search for the cancer-causing agent. Twenty-five scientists and technicians now work with thousands of mice, hamsters and monkeys. And the virus work now dominates a new building at the Buffalo institute.

Telling the story to his fellow surgeons, Dr. Grace said that many cancers in mice, rabbits and other species can be brought on by viruses. These ultramicroscopic bundles of chemicals, which in some forms are responsible for polio, colds and a host of other diseases, usually can be recovered from the growing animal cancer. Injected into another animal, the viruses caused the malignant disease there.

But there is only one case in which a “virus-like” substance recovered from human leukemia had produced a leukemia in mice. Whether that virus actually came from the human tissue or was a contaminant is still a matter of controversy. About three years ago, Dr. Grace discovered a chemical difference bewteen normal human tissue and cancer tissue. In trying to run down the difference, Dr. Grace’s mind again turned to infection with viruses as a possibility.

Why not try infecting mice with human cancers? Other scientists were able to do this by blasting the mice with X-rays or chemicals and then transplanting a lump of cancer flesh. There was only the one doubtful case on record of a virus recovery from a human being. Dr. Grace then recalled the experiments of Dr. Ludwig Gross of the Veterans Administration Hospital in the Bronx, N.Y. Dr. Gross could transfer a virus cancer from mouse to mouse by injecting cancer extracts — not lumps of tissue — into the new-born animal, a creature literally as big as a peanut.

Dr. Grace decided to try it with extracts of human cancer. First he ground up human cancer tissue removed at surgery. Next he extracted the solid matter and all cells. To make sure there was no solid matter left, he filtered the extract. Only a virus or a non-living chemical could slip through the filter’s fine pores. He injected about 1,000 new-born mice and waited for cancers.

To make sure he wasn’t deluding himself, Dr. Grace kept a controlled group of the same family of mice. He also tried to “grow” a human cancer virus in test tubes and injected that stuff too. But neither group developed the malignant disease. The mice injected with the filtered extracts of living cancer did develop cancer, particularly pregnant mice. Although Dr. Grace took his tissue from twenty different human cancers, most of the diseased mice developed malignant breast growths.

What is Dr. Grace looking for now? He and his colleagues, Dr. J.A. DiPaolo, Dr. E.A. Mirand, both Ph.D.’s, and J.R. Haas want to identify the virus or viruses precisely. They want to grow the virus in test tubes. But there is a danger in that procedure. A virulent form of the virus could in principle infect the workers. ”We’ve turned our laboratory into Fort Know,” Dr. Grace said at an interview. “You can’t get in and out without taking a shower. We’ve already increased the deadliness of the virus so that it produces cancer in mice ib seven days rather than forty.” This was done by transferring it from animal to animal.

And eventually Dr. Grace looks toward making a preventive vaccine against disease. This can be done either with a killed virus, with the Salk technique, or with a weakened cancer virus. It’s a long way to go Dr. Grace admits, but he never again wants to watch a child die of leukemia.

 

NY Daily News: Imus Swears at Young Cancer Patient

“Anywhere else that happened in this kid’s life,” says Imus, “they’d send him to the infirmary for a couple of days. And I know you can’t blame parents of a kid with cancer for being cautious. But after our medical people checked him and said he was okay, he kept going. He told me later it was one of the great moments of his life. To the other kids he was a hero.”

Stories like that are why Imus launches the 15th annual WFAN (660 AM) Radiothon tomorrow morning.  The Radiothon, which has raised more than $25 million, benefits three organizations: the Tomorrow’s Children Fund at Hackensack University Medical Center, the Imus Ranch and the CJ Foundation for SIDS, created in memory of Carly Jenna Hollander. Carly Jenna, daughter of former WFAN general manager and current Infinity Broadcasting President Joel Hollander, was a SIDS victim in 1993.

So the Radiothon has always had a somber foundation, and Imus’ guests include cancer patients, family members of SIDS victims and others whose stories aren’t light morning radio talk.  ”It gets hard,” Imus admits. “It’s not fun for anyone to talk about all this.”  But, being Imus, he finds some of his motivation through irritation.

“What I want to know,” he says, “is why the government won’t fund more cancer research. Something like 50% of the population will get some form of cancer, so I don’t understand why our representatives, just for self-preservation, won’t commit more to research. The money is there. They spend it on other things.  ”Breakthroughs are happening all the time. But so much of it has to come from private financing.”

That includes the Radiothon, which Imus kicks off 5:30-11 a.m. tomorrow at the New York Stock Exchange.  WFAN’s next two shows, Jody McDonald and Sid Rosenberg, 11 a.m.-1 p.m., and Mike and the Mad Dog, 1-7 p.m., will be live from the Museum of Television & Radio, 25 W. 52nd St. The public is invited to drop in.

After the Mets’ game, Steve Somers and then Joe Benigno will keep it going overnight. Imus wraps it up 5:30-10 a.m. Friday from the Don Imus-WFAN Pediatric Center at Hackensack Hospital – a facility built largely with Radiothon funds.  Sports and entertainment packages, including Super Bowl and Grammy tickets and a trip to Boston on the Yankees charter, will be auctioned on-air all day.

“Imus is the driving force, but I can’t say enough about how the team pitches in,” says WFAN program director Mark Chernoff. “It’s become a station event.”  Imus and his wife, Deirdre, bring about 500 kids a year to the ranch and Imus says they’re working on ways to bring more. “Last year,” says Imus, “one of the kids told Deirdre, ‘Everywhere else we’re the junior varsity. Here, we’re the varsity.’ That’s the kind of thing that makes all the work worthwhile.”

 

Marijuana May Stall Brain Tumor Growth

Researchers say the cannabinoids found in marijuana may aid in brain tumor treatment by targeting the genes needed for the tumors to sprout blood vessels and grow. Their study showed that cannabinoids inhibited genes needed for the production of vascular growth factor (VEGF) in laboratory mice with glioma brain tumors and two patients with late-stage glioblastoma multiforme, a form of brain cancer.

VEGF is a protein that stimulates blood vessels to grow. Tumors need an abundant blood supply because they generally grow rapidly. So when VEGF is blocked, tumors starve from lack of blood supply and nutrients. Blocking of VEGF constitutes one of the most promising tumor-fighting approaches currently available, says researcher Manuel Guzman, professor of biochemistry and molecular biology, at the Complutense University in Madrid, Spain, in a news release.

Guzman says the findings suggest VEGF may be a new target for cannabinoid-based treatments. Previous studies have shown that cannabinoids could inhibit the growth of tumor-associated blood vessels in mice, but until now little was known about how they worked. The results of the study appear in the Aug. 15 issue of the journal Cancer Research. Cannabinoids May Help Starve Tumors

In the study, researchers looked at the effects of cannabinoid treatment on gliobastoma multiforme, a form of brain cancer that affects about 7,000 Americans each year. It’s considered one of the deadliest forms of cancer and usually results in death within one to two years after diagnosis. Treatment typically involves surgery, followed by radiation and/or chemotherapy. But despite these efforts to destroy the tumor, this type of brain tumor often survives and starts growing again, which is why researchers are looking for novel ways to attack it.

In order to grow, all tumors require a network of blood vessels to feed them, and they create this network through a process known as angiogenesis. VEGF is critical to this process. In the first part of the study, researchers induced brain cancer in mice and then treated them with cannabinoids. They then analyzed the genes associated with the growth of blood vessels in the tumor and found that cannabinoids inhibited several of the genes related to VEGF. In the second part of the study, researchers injected cannabinoids into tumor samples taken from two human glioblastoma patients.

“In both patients, VEGF levels in tumor extracts were lower after cannabinoid inoculation,” says Guzman. Researchers say more study is needed but the results suggest that cannabinoid-based therapies may offer a new alternative for treatment of these otherwise untreatable brain tumors.

 

American Cancer Society a Danger to Science?

The credibility of the peer review process has come under vehement attack.  Scientists who receive no-strings-attached financial support for their research from demonized industries – tobacco, pharmaceuticals, and food, among others – are no longer deemed trustworthy.

Apparently, the rigors of the peer review process – even in the world’s best science and medical journals – in addition to full disclosure requirements, isn’t enough to prevent “biased” studies from being published.  Activists – displeased with results that undermine their agenda – cry bias, and prestigious science and health organizations cave, preferring to appease the advocates, rather than allow the scientific method to weed out bad science.

One of the country’s most distinguished cancer organizations has succumbed to the prohibitionist faction of the anti-tobacco movement’s demagogic rhetoric.  Accepting and adopting these crusaders’ guilt-by-association arguments at face value, rather than identifying flaws in the research results they oppose.

Earlier this year, the American Cancer Society (ACS) passed a resolution barring scientists who receive financial support from the tobacco industry from receiving ACS grants.  Responding to news of the resolution, Dr. Elizabeth Whelan warned ACS (see letter below) against their injurious adoption of such a litmus test.  Using funding as a basis for rejection is detrimental to the process of providing unbiased, peer-reviewed health information.

Such policies have unseen costs and unintended consequences.  They may produce biased research by cherry-picking authors and results and confusing public debate – mirroring the tobacco industry’s stratagem.  Further, they set a dangerous precedent by giving opponents of sound science a new weapon.  If the science is faulty, we should use science itself, not ad hominem or innuendo, to detect the problems.

ACS’s response to our criticsm?  Six months later, we’re still waiting.  Regardless of whether we ever receive a reply, we hope ACS got the message. Putting science ahead of ideology is best for cancer patients as well as the general public, who rely on good science – that which is able to survive the rigors of peer review – not simply good intentions.

 

USA Today: “Plant foods to the rescue”

Scientists who study nutrition paint a very different picture.

A growing body of research shows that, once inside the body, fruits and vegetables spring into the role of superheroes, fighting cancer and other diseases in at least eight simultaneous ways. And, like the Superfriends, they seem to work better as a team. Some phytochemicals, or plant chemicals, knock out carcinogens and fight inflammation. Some regulate how quickly cells reproduce and spur old, damaged cells to self-destruct. Other plant chemicals perform “routine maintenance” on DNA, says Jeff Prince, vice president for education at the Washington-based American Institute for Cancer Research.

Doctors caution that recent research indicates that fruits and vegetables may not provide as much protection against cancer as once believed. In the past five years, studies have shown that weight control may be more crucial, says Walt Willett, chairman of the nutrition department at the Harvard School of Public Health.

Yet most experts agree that the body needs a variety of these phytochemicals – there are more than 25,000 of them – to stay in top form. That’s why so many nutritionists no longer stress individual “power foods,” Prince says, but instead promote a “plant-based” diet of fruits, vegetables, whole grains, beans and nuts. Preliminary research indicates these foods bring out the best in each other and magnify their protective effects.

At the cancer institute’s annual scientific conference in July, researchers from the University of Illinois-Urbana described their research feeding tomatoes and broccoli to lab rats that had prostate cancer. The tumors of rats that were fed both vegetables shrank far more than those of animals who ate either food alone. Researchers stressed, though, that people do not necessarily react the same way as animals and that many larger studies need to be done to confirm these results.

“The take-home message is not that experts recommend tomatoes and broccoli,” Prince said at the conference. “We’re not going to find a single source that fights disease. What’s important is the interaction of thousands of plant chemicals.” Humans evolved to depend on a rich diet of 800 plant foods, says David Heber, director of the University of California-Los Angeles Center for Human Nutrition. Today, he says, most people eat three, and those are often french fries, ketchup and iceberg lettuce.

Yet some potentially potent plant foods, experts say, are exotic varieties that Americans rarely sample: herbs such as ginseng; spices such as turmeric, used in Indian cooking; and Reishi and Maitake mushrooms from Japan. Heber suggests that people select their five to nine recommended daily servings of fruits and vegetables from seven color groups, such as purple grapes or yellow squash, whose colors are produced by disease-fighting chemicals called carotenoids.

Scientists have identified only a handful of the thousands of potentially beneficial plant chemicals, says Daniel Nixon, author of The Prostate Health Program and president of the Institute for Cancer Prevention in New York. People who would rather pop dietary supplements instead of eating the real thing may miss out on proven health promoters such as fiber, as well as compounds that scientists have yet to discover, Nixon says. Last week, the American Heart Association published an advisory finding that antioxidant supplements do not prevent heart disease. In some studies, supplements with beta carotene – the chemical that colors carrots orange – increased the risk of cancer.

Plants vs. disease

Plant foods, however, may help prevent a number of diseases, says Rachel Brandeis of the American Dietetic Association. Antioxidants found in vegetables neutralize dangerous molecules called “free radicals,” which are produced by smoking and radiation, as well as everyday activities of the body. Left to themselves, free radicals attack healthy cells and may lead to plaques in the arteries and even Alzheimer’s. They also can damage DNA in ways that lead to cancer. As plants evolved, they developed antioxidants to fight free radicals, Heber says. Humans grew to depend on fruits, vegetables and nuts to provide these vital defenses. That may explain why, without a rich plant diet, people are more vulnerable to disease. Diets rich in plant compounds, on the other hand, may prevent a variety of ailments.

At a meeting of the Alzheimer’s Association last month, for example, researchers presented the results of a six-year study of 3,000 senior citizens. In the study, people who consumed lots of vitamin C and carotenoids, both through food and supplements, scored higher on reasoning tests. Carotenoids are found in squash, strawberries and other fruits. According to another study presented at the meeting, vegetables such as spinach and broccoli – which contain vitamin C and carotenoids, as well as the vitamin folic acid – were found to slow cognitive decline.

Other things that appear to lower the risk of Alzheimer’s include vitamin E, found in wheat germ, and fatty fish, such as salmon and mackerel, which are rich in omega-3 fatty acids, according to the Alzheimer’s Association. Scientists say they still have many questions about antioxidants: Can they fight cancer at any stage of the disease or at any age? Or do people benefit only if they consume these foods from infancy? Under which circumstances might antioxidants promote disease, rather than healing?

Scientists have identified at least a handful of the ways that plant foods appear to fight disease, says Cheryl Rock, a professor of nutrition at the University of California-San Diego Cancer Center. * By mopping up free radicals, antioxidants such as the beta carotene in sweet potatoes or the vitamin E in almonds prevent cell damage. Another class of chemicals called flavonoids have been shown to activate the body’s natural DNA repair system.

* Fruits and vegetables often are high in potassium, which can help control blood pressure.

* Antioxidants may interrupt a process leading to inflammation, which appears to play a role in cardiovascular disease and cancer. Vitamin B6, found in bananas, and folic acid, found in broccoli and leafy greens, both lower levels of homocysteine, which has been linked to hardening of the arteries, heart attacks, strokes and dementia.

* Chemicals such as beta carotene also help regulate the natural cycle of cell birth and death, telling cells when to divide, differentiate into new types or recycle themselves. Keeping this process under tight control can prevent cancer, Rock says.

* Phytochemicals in foods such as Brussels sprouts, red cabbage and kale may help prevent cancer by activating enzymes that break down carcinogens.

Antioxidants vs. angiogenesis

* Emerging research suggests that antioxidants may shut down a process called angiogenesis, by which tumors recruit blood supplies that help them grow and spread, says William Li, president of the Angiogenesis Foundation. Scientists are investigating links between angiogenesis and compounds found in foods such as licorice, blueberries and garlic, Li says.

Researchers who studied tumors in mice were able to cut back the number of new blood vessels by 70% simply by replacing their water with green tea, Li says. Scientists have not proved this link in humans.

* Plant foods such as whole-grain cereals and oats are loaded with fiber. In a study of 40,000 male health professionals, high-fiber diets reduced the risk of coronary heart disease by 40%. Diets filled with cereal fiber also may help prevent diabetes and a painful intestinal inflammation called diverticular disease. “Mother Nature is cleverer than all of us and has laced many of our favorite foods with things that can be helpful,” Li says. “Ancient cultures have long recognized that your diet can be healing, and
scientists are only now beginning to understand why.” Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns – ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets.

Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets. Tomatoes The carotenoid lycopene. Eating several servings a week may reduce the risk of prostate cancer up to 35% and also may reduce the risk of heart attack and stroke. To get the most lycopene, cook tomatoes with a little “healthful” fat, such as olive oil.

Whole-grain breads and cereals Fiber and antioxidants. May lower the risk of heart disease by 40%. May also help prevent diabetes. Read labels to make sure that the first ingredient in the bread says whole wheat, not just wheat or “stone-ground wheat.” Salmon, mackeral, sardines Omega-3 fatty acids. Reduces risk of heart disease, diabetes and possibly Alzheimer’s and cancer. Reduces inflammation, which may help prevent or relieve symptoms of arthritis. Contains vitamin D, which builds strong bones and may protect against colon cancer. Cooked, to kill microorganisms and parasites. Broiled, to eliminate contaminants found in freshwater fish. For canned fish, serve with the soft, mashed, calcium-rich bones.

Spinach and other leafy greens Folic acid. This may reduce risk of birth defects, heart attack, Alzheimer’s, depression and inflammation. Folic acid also reduces the risk of fractures. Potassium lowers blood pressure and the danger of strokes. The carotenoids lutein and zeaxanthin may help fight age-related eye disease. Antioxidants called flavones may reduce breast cancer risk.  Fresh or lightly steamed to preserve vitamin C; with nuts, olive oil or avocados, whose fat helps to increase absorption of antioxidants.

Blueberries or other berries Antioxidants such as vitamin C. These may reduce risk of heart disease, cancer, mental decline and other diseases of aging. May help prevent urinary-tract infections by inhibiting bacteria.  Fresh, raw or lightly cooked. Wash them just before serving to avoid mold and bruising. Canning blueberries removes half of the vitamin C. Sweet potatoes Carotenoids, which may help reduce the risk of Alzheimer’s. Beta carotene also may lower the risk of cancers of the larynx, esophagus and lungs. Baked or boiled.

 

NEW VERSION OF TEST FOR CANCER-CAUSING AGENTS NEEDS NO ANIMALS

A new version of a popular test for cancer-causing agents is cheaper, more sensitive and, best of all, animal-free, thanks to a U of G researcher. Prof. David Josephy, Chemistry and Biochemistry, has developed a way of testing substances for cancer-causing potential without using animal tissue. Instead, his version of the Ames test involves gene splicing.

“Nobody has figured a way around using animals until now,” says Josephy. “We hope that no more animals will have to die for the sake of the Ames test.” Two decades ago, the Ames test (named after inventor Bruce Ames, a bacterial geneticist from the University of California at Berkeley) was heralded as a breakthrough in cancer research. Ames’s goal was to eliminate the use of animals in tests for cancer-causing or “mutagenic” agents.

In his efforts to put an end to animal use, Ames came up with a way to use animal tissue for his tests, rather than the whole animal. In animals, cancer-causing agents are inactive until they’re chemically changed or “metabolized” by certain enzymes. When they’re changed, they become dangerous because they’re converted into different forms of chemicals.

Ames chose rodent liver extracts for his test because the liver contains more metabolic enzymes than other organs do. In a test tube, he combined liver cells and bacteria. He used bacteria because they’re so small that billions of cells can be affected by the mutagen in one test, making results easier to observe. When a potential cancer-causing agent is introduced into the test tube, it’s metabolized by the enzymes in the liver and causes DNA damage or mutations to the bacterial cells. DNA damage mutates cells, which results in cancer in animals.

The test has enabled researchers to identify carcinogens such as the charring on burnt food and a chemical used to fireproof children’s pyjamas, which was banned after the discovery was made. The Ames test used only a portion of a rodent’s liver. That meant it reduced the use of animals needed to detect suspected mutagens because one liver provided enough material for hundreds of tests. With the Ames test, mutagen-detection laboratories need to use only a few dozen rodent livers each year instead of the thousands of animals that lifetime feeding tests would require.

Now Josephy has taken that a step further. He has completely eliminated the need for animals to be involved. In the last few years, researchers have identified the gene — called P4501A2 — that makes the enzyme needed to metabolize carcinogens so they become mutagenic. Different enzymes metabolize different carcinogens; the enzyme P4501A2 metabolizes one class of compounds called aromatic amines, the carcinogens in charred material.

Josephy spliced the P4501A2 gene into the bacterial cell responsible for producing the metabolizing enzyme that identifies it as a mutagen. By splicing the gene into the bacteria, he’s made it possible for the bacteria to produce the required enzyme, so that no rat liver is needed. As a result, when potential mutagenic chemicals are introduced, the bacteria are a complete mutagen-detecting package  in themselves.

Josephy has installed a clone of the human P4501A2 gene into the bacteria to make the test even more representative of human metabolism. The cloned human genes come from Peter Guengerich, a collaborator at the Vanderbilt University School of Medicine in Nashville. “It means we can do a much more sophisticated mutagen analysis than we could in the past,” says Josephy. “We’re fulfilling Ames’s goal.” This work is sponsored by the National Cancer Institute of Canada and the Natural Sciences and Engineering Research Council.

 

Male breast cancers ‘more common’

More men are developing breast cancer – but most fail to spot tumours until they are at an advanced stage, a study has warned. University of Texas research found that, while men are far less likely to develop breast tumours than women, the numbers are increasing. Writing in an online edition of the journal Cancer, they warn men seem to be unaware they can develop the cancer.

UK experts said the cancer was rare, but men should be aware of changes. It is important to visit your GP straight away if you notice any change in your body that is not normal Henry Scowcroft, Cancer Research UK The researchers looked at a National Cancer Institute data on cancer incidence and survival in the US from 1973 to 1998. They found that, over the last 20 years, the incidence of male breast cancer had increased from 0.86 to 1.08 per 100,000 men. They then examined 2,524 cases of male breast cancer and 380,856 cases of female breast cancer on the database, diagnosed over that period. The researchers found that compared to female patients, men tended to be significantly older when they were diagnosed – 67 years versus 62 years of age.

They were also more likely to have later stage disease and had more spread of the cancer to their lymph nodes. ‘Easier to spot’ Professor Sharon Giordano, who led the research, said: “Male breast cancer is rare, accounting for less than one per cent of all breast cancer. “But she said: “Men should be alert to the possibility that the disease could affect them.” Professor Giordano added: “It’s perhaps ironic that tumours in men are easier to feel than they are in women, yet the disease is being discovered at a later stage in men than in women.” The researchers say that part of the reason for late diagnosis may be that men assume they are experiencing a benign condition called gynecomastia, or breast tissue growth, that affects about a third of males at some point in their lives.

The condition, which is common in teenage boys, can come and go over a man’s lifetime. Professor Giordano said: “Men may think new growth of breast tissue is just another occurrence of this condition.” The team also found that men often had more larger tumours which had spread further and more aggressive forms of cancer when they were diagnosed.However, survival rates for men and women were no different. The researchers said men were more likely than women to have oestrogen-positive tumours. Professor Giordano: “We are not sure why this is so, but it may indicate some important differences in tumour biology.”In addition, this implies that use of tamoxifen in men may be as beneficial as it is to many women.” She added: “Now that we have a clearer understanding of the biology of breast cancer in men, further research is needed to determine the optimal treatment for men.”

‘Campaigns aimed at women’

Henry Scowcroft, Science Information Officer at Cancer Research UK said: “Breast cancer is very rare among UK men, and when it does occur, it tends to do so between the ages of 60 and 70.”Only about 300 men are diagnosed with the disease each year, compared with about 41,000 new cases in women. Because of this, most breast cancer awareness campaigns are aimed at women. “While Cancer Research UK does not recommend that men, especially young men, examine themselves regularly, it is important to visit your GP straight away if you notice any change in your body that is not
normal.”